Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
New WHO guideline on care and treatment of chronic hepatitis C
Hepatitis C Treatment Snapshots: Daclatasvir
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Community group taking actions to enable greater access for generic HCV treatment
